Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Big Pharma's Uphill 2013 Battle
Motley Fool
Wed, 02/6/13 - 11:02 am
Big Pharma
Merck
Pfizer
JNJ
Bristol-Myers Squibb
Novartis
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
diabetes
Merck
SGLT2 inhibitor
Bristol-Myers Squibb
AstraZeneca
JNJ
Array Biopharma
Januvia
Amgen
Forixga
GKAs
Pfizer, Bristol-Myers, Johnson And Johnson: Do They Have The Next Plavix, Or Vioxx?
Seeking Alpha
Sat, 02/2/13 - 12:03 pm
JNJ
Bristol-Myers Squibb
Pfizer
AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE
Bloomberg
Fri, 02/1/13 - 10:57 am
AstraZeneca
Forxiga
Bristol-Myers Squibb
UK
diabetes
Two Peas in a Pharma Pod
Motley Fool
Fri, 02/1/13 - 10:54 am
Pfizer
Bristol-Myers Squibb
earnings
Bristol-Myers seeking buyer for Mexico, Brazil brands-WSJ
Reuters
Fri, 02/1/13 - 10:45 am
Mexico
M&A
Brazil
Bristol-Myers Squibb
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wed, 01/30/13 - 04:16 pm
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
Pfizer
Sanofi
Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
Seeking Alpha
Tue, 01/29/13 - 10:23 am
dividend
Bristol-Myers Squibb
Eliquis
Yervoy
PDL-1
Abilify
Forixga
Bristol-Myers Squibb Company Earnings Call Insights: Tax Rate Drop and PD-1 Readout
Wall Street Cheat Street
Sun, 01/27/13 - 11:19 am
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must See
Wall Street Cheat Street
Sun, 01/27/13 - 11:09 am
Bristol-Myers Squibb
earnings
Amgen
Celgene Corporation
AmerisourceBergen
Earnings Season: It's All About Expectations
Motley Fool
Sat, 01/26/13 - 11:59 am
Bristol-Myers Squibb
AstraZeneca
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:40 am
Vivus
Theravance
Roche
MAP Pharmaceuticals
M&A
Immunogen
GSK
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Bristol-Myers beats forecasts, as newer drugs deliver
Reuters
Thu, 01/24/13 - 10:23 am
earnings
Bristol-Myers Squibb
Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha
Tue, 01/22/13 - 10:43 am
age-related macular degeneration
Lpath
Merck
Pfizer
Bristol-Myers Squibb
Roche
ShangPharma
Bristol-Myers Preview: Will it Miss?
Yahoo/Zacks
Mon, 01/21/13 - 10:56 am
Bristol-Myers Squibb
earnings
Big Pharma Diabetes Face-Off
The Motley Fool
Sat, 01/19/13 - 11:07 am
Pharma
diabetes
Bristol-Myers Squibb
Astra Zeneca
Novo Nordisk
GlaxoSmithKline
Bristol-Myers Squibb and Quest Diagnostics Facing Healthcare Hurdles
Wall St. Cheat Sheet
Thu, 01/17/13 - 08:44 am
Quest Diagnostics
Bristol-Myers Squibb
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
Bristol-Myers Tries To Settle Hep C Patient Claims
Pharmalot
Wed, 01/16/13 - 08:16 am
hepatitis C
Bristol-Myers Squibb
2 BioPharma Stocks With Eroding Profits: Buy or Sell?
Motley Fool
Tue, 01/15/13 - 11:33 am
AstraZeneca
Pfizer
Bristol-Myers Squibb
Pages
« first
‹ previous
…
63
64
65
66
67
68
69
70
71
…
next ›
last »